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http:WHAT THIS PAPER ADDS
Only a few larger studies on surgical outcome of aorto-arterial reconstructive surgery in pediatric patients with
renovascular hypertension exist in the current literature. This study presents the early and long-term results
after reconstructive surgery, the etiology, and clinical symptoms of 44 patients. Those results may support
further indications for operative treatment of renovascular hypertension in pediatric patients.Objectives: This retrospective study presents the early and late results of pediatric patients who underwent
reconstructive surgery for renovascular hypertension (RVH) between 1979 and 2009.
Methods: From 1979 to 2009 44 patients (male 22; mean age 13  5.2 years, range 1e19 years; early childhood
7 [1e6 years], middle childhood 5 [7e10 years]; adolescents 32 [11e19 years]) with renovascular hypertension
underwent surgery for abdominal aortic stenoses (n ¼ 6), renal artery stenosis (RAS) (n ¼ 25) or for combined
lesions (n ¼ 13). Nineteen aortic stenoses (bypass/interposition 10/5, patch dilatation/thromboendarterectomy
2/2), 51 renal arteries (interposition 36, resection þ reimplantation 13, patch dilatation/aneurysmorraphy 1
each), and 10 visceral arteries (resection þ reimplantation 6, interposition 3, patch dilatation 1) were
reconstructed. Each patient underwent duplex studies and if required intra-arterial digital subtraction
angiography. Reoperations within 30 postoperative days were required in four (9%) of the patients for occlusion
of four arteries (6%), achieving a combined technical success rate of 94%.
Results: After 114  81 months 36 patients were re-examined by duplex and magnetic resonance angiography (2
not surgery-related deaths 7/12 years postoperatively, 8 patients lived abroad). Twelve patients had required a
second and three a third procedure. Hypertension was cured early/late postoperatively in 27%/56%, improved in
41%/44%, and remained unchanged in 32%/0%. Best late results were obtained in patients with isolated aortic
disease and at the age of middle childhood.
Conclusions: Reconstructive surgery for pediatric RVH yields good results at every age and every type of lesion.
However, these children should be followed up closely and to avoid early cardiovascular disease and death in
later life, surgery should not be delayed.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Pediatric hypertension is a rare entity and presents in
approximately 1e4.5% of children.1 Most children suffer
from secondary hypertension due to renoparenchymal andse authors contributed equally.
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//dx.doi.org/10.1016/j.ejvs.2013.12.012renovascular disease.2 Renovascular hypertension (RVH)
results from renal artery stenoses (RAS), mostly due to
ﬁbromuscular dysplasia (FMD) or from stenoses of the su-
pra- and/or inter-renal aorta with associated stenoses of the
renal (90%) and visceral arteries (20e40%), which were
deﬁned by Sen et al.3 as “middle aortic syndrome” (MAS) in
1963. Etiology of MAS can be primary due to congenital
abdominal aortic coarctation (AAC)4 and secondary with
mainly inﬂammatory (mostly Takayasu’s arteritis [TA])5 or
genetic origin (mostly neuroﬁbromatosis [NF] type 16).
RVH is difﬁcult to control with medication7 and most
patients require percutaneous transluminal angioplasty
(PTA) or surgical reconstruction depending on the type of
510 W. Sandmann et al.lesion. To date, only a few long-term studies after surgical
intervention in pediatric patients exist. Therefore, a large
number of pediatric patients who underwent reconstructive
surgery for RVH is presented. In the context of an endo-
vascular approach as the ﬁrst-line approach in nearly all
vascular ﬁelds, this paper adds an important argument for
reconstructive surgery.PATIENTS AND METHODS
All patients up to 19 years of age who had undergone
reconstructive surgery, performed by the same senior sur-
geon (W.S), for RVH between 1979 and 2009 were included.
All patients had undergone substantial preoperative imag-
ing and renal ﬂow studies as well as early postoperative
duplex and if required intra-arterial digital subtraction
angiography (i.a. DSA). Pre- and early postoperative data
were collected from patients’ records and all patients were
invited for a current follow-up examination. The study was
approved by the Ethics Committee.
Hypertension was graded by systolic and diastolic blood
pressure (BP) levels of three or more clinical measurements
and the number of antihypertensive drugs. According to the
literature8 BP levels and hypertensive ranges for patients
17 years vary greatly and cannot be compared easily.
Therefore, an objective age-adjusted blood pressure ratio
(AABPR) for systolic and diastolic BP levels was generated
by dividing the individual BP by the BP known to be normal
in normotensive individuals (hypertension threshold). In
order to obtain this threshold, data for individual age and
gender, the 95th percentile of height with the highest value
of normotensive BP levels, which is the 90th percentile of
BP8 were combined. The values for age-adjusted normal
blood pressure in relation to height were taken from cur-
rent tables found in the Fourth Report on the Diagnosis,
Evaluation, and Treatment of High Blood Pressure in Chil-
dren and Adolescents.8 BP levels for patients >17 years
were evaluated by the JNC7 classiﬁcation.9 Furthermore,
cure was deﬁned as achieving normo- or pre-hypertensive
BP levels. If patients still required drugs to obtain these
levels, it was deﬁned as improvement. If diastolic levels
were still hypertensive (<95th percentile) without or
despite medication and if they had not improved more than
15% compared to preoperative levels, it was considered as
no improvement. This classiﬁcation has been similarly used
by other authors.5,10,11 Signiﬁcant changes between pre-
and postoperative values (systolic/diastolic BP, comparison
of the age groups, comparison of the disease groups) were
calculated using the Student t test, ANOVA, and Studente
NewmaneKeuls method as a post hoc test. Fibromuscular
dysplasia was deﬁned by angiographic and intraoperative
histopathological specimens. The glomerular ﬁltration (GFR)
rate was estimated using the Schwartz formula in children12
and the Mayo formula in adolescents.13
The surgical approach was determined with regard to the
extent and the localization of the lesion. Aortic dysplasia
extending to above the diaphragm was approached by
thoraco-abdominal incision (n ¼ 7). Those with lesions inthe abdominal aorta below the mesenteric arteries were
approached through a midline abdominal incision (n ¼ 36).
In the single patient with thoracic aortic coarctation a
thoracotomy was performed (n ¼ 1).
The decision about the type of graft and prosthesis was
made on the base of extent and location of the lesion(s). In
general, prosthetic material was implanted for aortic le-
sions, while avoiding end-to-end anastomosis but with a
diameter appropriate for later growth, and for reconstruc-
tion of renal and visceral arteries autologous material
(greater saphenous vein [GSV], hypogastric artery) was
preferred. Some rare exceptions are described later in the
text (i.e. homologous vein from parents; PTFE in older
adolescents).
In general, all end-to-end anastomoses were performed
with single stitches; end-to-side anastomoses were per-
formed with a larger oblique lumen to allow for growth.
Heparin was used in lower doses than in adults; for pre-
vention of strictures the conformability of the individual
replacement material and the hemodynamics had to be
respected.RESULTS
Patients
A continuous series of 44 patients (22 male) between 1 and
19 years of age (mean age 13 years, SD 5.2) was included
into this study. With the exception of one child (early
childhood) all patients had normal renal function pre-/
postoperatively calculated using the Schwartz formula for
the GFR in children. The group was divided into age groups
of early childhood (1e6 years; n ¼ 7, 16%; 5 male, 2 female;
mean age 3 years), middle childhood (7e10 years; n ¼ 5,
11%; 3 male, 2 female; mean age 9 years), and adolescence
(11e19 years; n ¼ 32, 73%; 14 male, 18 female; mean age
16 years), and disease groups including patients with iso-
lated RAS (or aneurysms in a single case) (renal; n ¼ 25,
57%; 13 male, 12 female; mean age 12 years), isolated
aortic stenosis (aorta; n ¼ 6, 13%; 2 female, 4 male; mean
age 12 years), and combined stenoses (combined; n ¼ 13,
30%; 6 male, 7 female; mean age 14 years). Ten patients
(23%; FMD 9, TA 1) in the renal group had been previously
treated at other hospitals: by surgery (n ¼ 8), PTA(s)
(n ¼ 1), or both (n ¼ 1).Diseases
The main etiology of renal diseases was FMD in 19 patients
(76%; 7 male; mean age 14 years). Other etiologies included
NF type I (n ¼ 3), and TA (occlusion of one bypass after
bilateral aortorenal bypasses), iatrogenic injury, and hypo-
melanosis of Ito, one case each. Aortic diseases were mostly
due to MAS (n ¼ 4; 67%; 1 female, 3 male; mean age 10.5
years). Other patients presented with thoracic aortic
coarctation (male, 17 years) and a post-traumatic thoraco-
abdominal calciﬁcation (female, 14 years). Combined ste-
noses were mostly caused by AAC (n ¼ 11; 6 female and 5
male, mean age 12 years). Other diseases were TA with
Figure 1. A 4-year-old boy presented to clinic with severe middle
aortic syndrome (MAS) and renal artery stenoses (RAS) of the
functional single left kidney. The patient complained of increased
fatigue, physical examination showed clear microsomia not pass-
ing the 10th percentile of length, hypertensive retinopathy stage 2,
and severe hypertension with BP levels of 140/76 mmHg under
medical treatment with four antihypertensive drugs. The patient
was treated by aorto-aortic interposition of homologous deep
femoral vein and reimplantation of all visceral and the left renal
artery. Anti-inﬂammatory medication was prescribed. At the time
of follow-up the patient (now 11 years old) had normotensive BP
levels of 120/55 mmHg still requiring four antihypertensive drugs.
CCDs showed no stenosis of the aorto-aortic interposition or left
renal artery. A step-by-step reduction of medication is planned.
Patient’s height is still under the 10th percentile.
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chronic Stanford type B dissection due to Marfan’s syn-
drome (male, 15 years). Other associated genetic comor-
bidities such as William’s syndrome were not found.
Abdominal aortic stenoses were mostly short and restricted
to aortic segment IV between diaphragm and renal arteries
(n ¼ 7). In seven patients the infrarenal aorta was included.
RAS were bilateral in 14 and unilateral in 22 patients. In-
testinal arteries were involved in seven patients, but only
ﬁve required surgical treatment (combined 4, renal 1) for
postprandial nausea and pain.
Clinical ﬁndings and symptoms
The main symptoms concerned headache (n ¼ 17), early
fatigue (12), epistaxis (n ¼ 8), abnormal sweating (n ¼ 7),
and intermittent claudication (n ¼ 7) especially in patients
with aortic stenosis. Other patients complained about
impaired vision (n ¼ 5) as an early sign of hypertensive
retinopathy, vertigo (n ¼ 5), dyspnea (n ¼ 5), and enuresis
(n ¼ 3). Five patients with renal and additional visceral
artery stenoses due to FMD complained of postprandial
nausea and pain, which was interpreted as abdominal
angina. The main clinical ﬁndings besides hypertension
included left ventricular hypertrophy (n ¼ 18), hypertensive
retinopathy (n ¼ 13), abdominal bruit (n ¼ 13), pathological
brachial/femoral BP gradient (n ¼ 12), and absence of pe-
ripheral pulses (n ¼ 7). Seven patients were asymptomatic
and there were no patients with severe cerebral symptoms
(including stroke) or heart failure.
Preoperative data
Arterial BP was medically well controlled in one patient.
Preoperative mean BP levels were 171 mmHg systolic (min.
120/max. 260, SD 31.1) and 104 mmHg diastolic (min. 65/
max. 160, SD 20.5). Preoperative medical treatment was
prescribed by family doctors or external centers. Sixteen
patients received no antihypertensive drugs, although BPs
were excessively high; the parents had decided on surgery
instead of trying medical treatment, which was understood
not to cure RVH. Twenty-eight patients received an average
of 2.1 medications (1/2/3/4, n ¼ 8/13/4/3) including b-
blockers (n ¼ 22), calcium channel blockers (CCBs) (n ¼ 15),
ACE inhibitors (n ¼ 8), diuretics (n ¼ 6), a1-blocker (n ¼ 4),
and reserpine, ARB, and clonidine in one patient each. The
average eGFR was 122.75  35.8 mL/minute.
Surgery and reconstructions
In all operations, a total of 70 vessels (right/left renal artery
28/23, aorta 19) were reconstructed. In the majority of
aortic reconstructions aorto-aortic bypasses (n ¼ 10), PTFE
(n ¼ 8) or Dacron (n ¼ 2), from either the distal thoracic or
the supraceliac to the distal infrarenal aorta were per-
formed. Another common technique was aorto-aortic
interposition (n ¼ 6) with PTFE (n ¼ 3) or Dacron
(n ¼ 1), or in cases of reconstruction of very small arteries
in very young children (Fig. 1) the homologous deep
femoral vein (DFV) from one parent after HLA and bloodgroup testing of both parents (n ¼ 2). Aortic patch plasty
using either Dacron or PTFE and a conventional throm-
boendarterectomy were performed in two cases each. The
preferred method of treating RAS was interposition (n ¼ 36;
aortorenal 31; prothesiorenal 5) of the GSV (n ¼ 26), hy-
pogastric artery (n ¼ 3), DFV (n ¼ 1), homologous GSV
(n ¼ 4), and, in single cases, PTFE or the resected infrarenal
aorta. In 13 patients renal arteries were reimplanted into
aorto-aortic interposition grafts (n ¼ 7), bypasses (n ¼ 4),
and into the original aorta (n ¼ 2). Renal patches (n ¼ 2)
were used in patients with RAS (n ¼ 1, Dacron) and
aneurysm of the renal artery (n ¼ 1; PTFE). Intestinal ar-
teries were mostly reimplanted into the aorta (n ¼ 2) or
into aorto-aortic interposition grafts after the stenosis had
been resected (n ¼ 4). Other visceral arteries were recon-
structed with interpositions of GSV (n ¼ 3) or patch dila-
tation with Dacron (n ¼ 1).Early postoperative results
Early postoperative results showed average systolic BP
levels of 125 mmHg (min. 100/max. 150; SD 10.2) and
diastolic levels of 79 mmHg (min. 55/max. 100, SD 7.5).
Twenty-one patients no longer required antihypertensive
drugs; the remaining patients received 1.3 drugs per patient
(1/2/3/5 ¼ 16/2/2/1) including b-blockers (n ¼ 15), CCB
Figure 2. A 12-year-old girl with middle aortic syndrome and ste-
noses of the renal and visceral arteries due to abdominal aortic
coarctation presented to the clinic with severe headache, epistaxis,
and recurrent signiﬁcant hypertension up to 195/115 mmHg in
June 2007. An aorto-aortic PTFE bypass with reimplantation of the
left renal artery into the bypass and the right renal artery into the
infrarenal aorta was performed and showed good postoperative
results with BP levels of 135/85 mmHg on b-blocker treatment.
Because of a recurrent stenosis mainly of the right renal artery
even after angioplasty intervention and recurrent hypertension
with BP levels of 165/100 mmHg bilateral prothesiorenal in-
terpositions of the greater saphenous vein (GSV) were performed.
At the time of follow-up the right renal artery had developed a
recurrent stenosis again and required an aorto (lumbar)renal
upside-down bypass with doubled GSV. To date, it shows good
results with BP levels at 125/70 mmHg under medical treatment
with a single b-blocker. Neither headache, nor epistaxis persisted.
512 W. Sandmann et al.(n ¼ 5), ACE inhibitors (n ¼ 3), diuretics (n ¼ 3), a1-blocker
(n ¼ 2), and dihydralazine and clonidine in one patient
each. The eGFR was 142.5 mL/minute (min. 72/max. 259;
SD 41). Kidney function was not inﬂuenced in patients with
ACE inhibitors. Combining the fact of lower BP levels and
fewer medications, an early postoperative beneﬁt in 69%
(n ¼ 30) of the patients, with cure in 27% (n ¼ 12) and
improvement in 41% (n ¼ 18) was observed. Fourteen
patients (31%) have not yet shown sufﬁcient improvement.
Complications
Primary procedures led to durable long-term results
without any need for reintervention in 68% of patients
(Table 1). Reoperations within 30 postoperative days were
necessary after an average of 6.6 days in 9% of patients
(n ¼ 4) in four vessels, accounting for a complication rate of
6% for all reconstructed vessels. Three of those with aor-
torenal interposition with GSV had thrombosis and required
a new graft (n ¼ 1) or thrombectomy and aortorenal
reanastomosis (n ¼ 2). The other patient with a previous
aorto-aortic interposition using homologous DFV and
reimplantation of all renal and visceral arteries developed a
unilateral occlusion due to an unresected venous valve, and
an aortorenal reanastomosis was performed after resecting
the persistent valve. Reoperations were performed imme-
diately after detecting restenosis or occlusion. Angioplasty
interventions for restenosis were not necessary in the ﬁrst
30 postoperative days and there was no early postoperative
mortality. Because of these complications the technical
success rate was 94% considering all 70 reconstructed
vessels.
Primary reintervention
After a mean of 23 months (min. 2.5/max. 68; SD 25), six
patients required PTA of eight vessels for recurrent RAS
(n ¼ 5) or stenosis of the proximal anastomosis at the
aorto-aortic interposition with homologous DFV (n ¼ 1)
(Table 1). Three patients did not need any further treatment
after angioplasty, while another three patients required one
reoperation each. Reoperations were necessary after a
mean time of 37 months (min. 3/max. 133; SD 7.8) in 13
vessels of 10 patients (23%). Recurrent RAS (n ¼ 5) occur-
ring after an average of 12.6 months (min. 3/max. 41, SD
16) were treated by PTFE graft interposition, aortorenal
homologous GSV interposition, bilateral prothesiorenal GSVTable 1. Results of aorto-arterial reconstruction: complications and re
n Total Main reason Re
Operations 44 25
Durable result 30 (68%) 18
Complications (in 30 days) 4 (9%) Thrombosis (n ¼ 3) 2 (
Reoperations (36.8 months
after primary procedure)
10 (23%) Recurrent RAS (n ¼ 5) 5 (
Reoperations (101 months
after primary, 36 months
after secondary procedure)
3 Various 1interposition, aortorenal GSV bypass for the right and GSV
interposition for the left renal artery and bilateral dilatation
with homologous GSV patches in one case each. Two pa-
tients developed aneurysms, one in an aortorenal GSV
interposition after 122 months which was treated by
aneurysmorraphy and enforced by PTFE wrapping (in the
meantime the patient had completed a pregnancy without
any problems) and one after 20 months in the proximal
anastomosis of an aortorenal GSV interposition, which was
treated by aortorenal PTFE interposition. One patient
required nephrectomy as the last resort because ofvisions.
nal Aorta Combined Infants Children Adolescents
6 13 7 5 32
(72%) 5 (83%) 7 (53%) 3 (43%) 3 (60%) 24 (75%)
8%) 2 (15%) 1 (14%) 3 (9%)
20%) 1 (17%) 4 (31%) 3 (43%) 2 (40%) 5 (16%)
2 1 2
Figure 3. Impact on hypertension over time. Hypertension
threshold is equal to 1, which means that ratios above 1 are hy-
pertensive blood pressure values, ratios below 1 are normotensive
blood pressure values.
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artery 5 months after the primary procedure. One patient
developed a stenosis of the proximal anastomosis of an
aorto-aortic PTFE bypass after 91 months, which was
treated by an aortoprothesial PTFE patch, and another pa-
tient a stenosis of a thoraco-abdominal interposition of
homologous DFV after 56 months, which was treated by
aorto-aortic PTFE interposition.
Secondary reintervention
In the latter patient a stenosis of the proximal bypass
anastomosis was treated by stenting. This patient and
another two required a second reoperation 53, 12, and 42
months after the primary reintervention due to recurrent
stenoses of proximal and distal anastomoses (PTFE
patches), recurrent RAS (aortorenal interposition of doubled
GSV) (Fig. 2), and an aneurysm of an already replaced
aortorenal GSV interposition graft (aortorenal internal iliac
artery interposition) (Table 1).
Long-term results
After an average of 114 months (min. 3/max. 356; SD 81.1)
36 patients (82%) with a mean age of 22 years (min. 8/max.
46; SD 9) presented to this center again. Six had moved
abroad, while one had died from a car accident, another
one from an aortic root rupture due to Marfan’s syndrome.Table 2. Comparison of disease groups and age groups.
Early results (%) Re-op rate
Beneﬁt C I NI
Renal (n ¼ 25) 68 28 40 32 32
Aorta (n ¼ 6) 67 34 33 33 17
Combined (n ¼ 13) 69 32 46 31 62
Infants (n ¼ 7) 28 14 14 72 57
Children (n ¼ 5) 60 20 40 40 40
Adolescents (n ¼ 32) 78 31 47 22 31
C ¼ cure; I ¼ improvement; NI ¼ no improvement; preop ¼ preoperPatients presented a mean systolic BP level of 126 mmHg
(min. 100/max. 175; SD 14.2) and diastolic levels of
74 mmHg (min. 50/max. 90; SD 8.6). BP levels had improved
signiﬁcantly from pre- to postoperative levels and
compared with the early follow-up levels (Fig. 3). Even if
early and late postoperative BP levels seemed to be equal,
they were in good normotensive ranges at a mean age of 22
years follow-up but still close to the hypertension threshold
at a mean age of 13 years postoperatively. Diastolic BP
levels, which are typically high in RVH, showed signiﬁcantly
better results than systolic ones. The majority received no
medication (n ¼ 20; 46%) or one antihypertensive drug
(n ¼ 9) at follow-up. Others needed two (n ¼ 4), three
(n ¼ 2), or four drugs (n ¼ 1). Those under medical treat-
ment received an average of 1.7 drugs per patient including
b-blockers (n ¼ 13), CCB (n ¼ 6), ACE inhibitors (n ¼ 3),
diuretics (n ¼ 3), and ARB (n ¼ 2). Kidney function was
unimpaired under ACE inhibitor treatment. At the time of
follow-up all patients had beneﬁted from the surgical pro-
cedures. In total, 56% (n ¼ 20) of all patients were cured,
while the other patients (n ¼ 16) still needed drugs for
optimal BP control. The mean eGFR was 130.32 mL/minute
(min. 84/max. 198.33; SD 25.1). The non-operated kidney of
the patient with the lowest eGFR was known to have an
impaired function due to an already treated congenital
stenosis of the renal pelvis years before. Patients with
reconstructed visceral arteries reported no persisting post-
prandial pain or nausea.Comparison of age and disease groups
The group of early childhood (presenting the highest pre-
operative AABPR) showed signiﬁcantly lower early post-
operative systolic levels than other patients, but on the
other hand signiﬁcantly better diastolic levels on a long-
term basis. They also enjoyed the smallest operative
beneﬁt after the primary procedure and required the
highest number of reoperations and medication (Table 2).
Adolescents showed the best early durability results and
operative beneﬁt and have maintained these results with
only few revisions and antihypertensive drugs to date. Pa-
tients in middle childhood (7e10 years) presented the best
long-term results and required fewer medications.
Comparing disease groups, no signiﬁcant differences
regarding systolic and diastolic BP ratio were detected. All
groups had similar rates and margins of early postoperative
beneﬁt between 67% and 69%, and patients not showing(%) Long-term results (%) Drugs/patient
(preop/postop/FU)Beneﬁt C I NI
100 52 48 0 1.9/0.8/0.4
100 80 20 0 0.8/1.2/0.6
100 40 60 0 0.6/1.2/0.9
100 43 57 0 1.9/1.0/1.3
100 80 20 0 2.2/0.4/0.2
100 50 50 0 1.1/0.8/0.5
ative; postop ¼ postoperative; FU ¼ follow-up.
514 W. Sandmann et al.sufﬁcient improvement (31e32%). On a long-term basis,
patients with combined diseases required more drugs and
reoperations, which is probably due to the higher number
of reconstructed vessels. Patients with isolated aortic ste-
noses had the best long-term outcome with a small reop-
eration rate.DISCUSSION
There are only a few large long-term studies on surgical
repair for pediatric RVH.5,11,14e16 Preferred techniques
(Table 3) for renovascular reconstruction in those and this
study were aortorenal reanastomosis with/without inter-
position of mostly the GSV and resection of stenosed seg-
ments with direct aortic reimplantation of the renal artery.
O’Neill5 used renal patches in 9e13% of cases, which were
used only twice (GSV/Dacron) for additional dilatation of
protheto- or aortorenal anastomosis. Lacombe14 practiced
extracorporeal surgery with kidney reimplantation (n ¼ 25)
or autotransplantation, which shows good results in chil-
dren with failed or technically impossible PTA or surgical
reconstruction.17 Some authors advised against the use of
autologous veins for aortorenal grafts in children because of
development of aneurysms in 20%.18 In this study, only two
patients developed aneurysmal dilatations of aortorenal
autologous GSV interpositions (whole graft n ¼ 1, proximal
anastomosis n ¼ 1). This accounts for a development of
aneurysms in 9% taking in to consideration all renal arteries
that have been reconstructed with autologous vein mate-
rial. Imaging of vein grafts usually showed dilatation
because of the higher arterial pressure than in the venous
system. Internal iliac arteries instead of vein grafts for
aortorenal interposition are recommended in the litera-
ture.11,14,19 For aortic reconstructions individual techniques
were used, most commonly interposition or bypasses using
PTFE grafts. Other authors did not use aortic interpositions
or thromboendarterectomy as were used in special casesTable 3. Comparison of surgical techniques in different studies.
Study Renal artery
Reanastomosis  IP RI Others
Stanley
et al.11
38% (n ¼ 42)
Aortorenal ¼ 37
Iliorenal ¼ 3
Splenorenal ¼ 2
53% (n ¼ 59)
Aortal ¼ 49
Renal ¼ 7
Into AMS ¼ 3
9%
(n ¼ 10)
Lacombe14 58% (n ¼ 57)
Aortorenal ¼ 23
Renorenal ¼ 7
Splenorenal ¼ 22
Hepatorenal/
gastroduodenorenal ¼ 5
17% (n ¼ 17)
Renal ¼ 17
ECS: 25%
(n ¼ 25)
O’Neill5 76% (n ¼ 29)
aortorenal ¼ 29
11% (n ¼ 4)
Aortal ¼ 4
0
Own results 71% (n ¼ 36)
Aortorenal ¼ 31
Prothetorenal ¼ 5
25% (n ¼ 13)
Aortal ¼ 13
AR: 2%
(n ¼ 1)
BP ¼ bypass; IP ¼ interposition/bypass; TEA ¼ thromboend
ECS ¼ extracorporeal surgery with kidney reimplantation or autotrans
a One prothetorenal anastomosis was additionally dilated with a Dacr(infrarenal aortic coarctation with degenerative plaques,
thoraco-abdominal aortic calciﬁcation), but bypasses in 37e
100%.5,11,14 Stanley et al.11 prefer PTFE to Dacron for patch
plasty in aortic reconstructions because of the risk of
developing an aneurysm. Aortic patches were used only
exceptionally in a patient with either abdominal (Dacron in
1979, oldest submitted case) or thoracic aortic coarctation
(PTFE) each.
Since 1980, PTA has been advertised as an alternative to
traditional vascular surgery for RVH.20 However, the role of
PTA in the treatment of RVH in growing individuals is
controversial.21 It is not possible in every patient (e.g. sol-
itary kidney) or type of lesion.14 In adults, technical success
rates of PTA are good (85e91%)22,23 and improvement in
atherosclerotic renovascular disease due to modern de-
velopments.22,23 However, BP results for unselected pa-
tients with RVH still show a modest response to PTA with
beneﬁts in only 55e56%.22,23 Apart from that, angioplasty
shows restenosis rates of 22e37%22,23 in children, possibly
due to the small diameter of vessels and the possible effect
of growth on the child’s vasculature.22,24 Nowadays PTA for
renovascular lesions is often preferred primarily to the
more invasive surgical intervention.14 Aortic angioplasty in
pediatric patients is usually combined with stenting,
although reports on stents are still limited. These in-
terventions can be followed by immediate relapses25,26 and
cause severe intimal injuries with possible thrombosis,
rupture, and pseudoaneurysmal formations.27,28 However,
aortoplasty in children with MAS may sometimes still be a
reasonable treatment for postponing the date of surgical
reconstruction.
The average diastolic BP showed a signiﬁcantly better
response than systolic BP. Results from Stanley et al.11 show
similar pre- and postoperative courses of hypertension. In
several studies, the long-term beneﬁt for pediatric patients
after surgical reconstruction for RVH is between 89% and
100%, with a low failure rate of 0e11% in the longAorta
Patch BP IP Patch TEA
0 37%
(n ¼ 11)
0 63%
(n ¼ 19)
0
0 100%
(n ¼ 6)
0 0 0
13% (n ¼ 5) 100%
(n ¼ 12)
0 0 0
2% (n ¼ 1) þ 1a 53%
(n ¼ 10)
25%
(n ¼ 5)
11%
(n ¼ 2)
11%
(n ¼ 2)
arterectomy; AR ¼ aneurysmorraphy; RI ¼ reimplantation;
plantation.
on patch.
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better long-term beneﬁt than those studies, there were
more patients still requiring drugs to obtain normo-/pre-
hypertensive levels, but no cases of failure. In this study
deﬁnitions for cure/improvement/failure were the same as
in other studies;5,10,11,14 only Stanley et al.11,29 considered
the use of ACE inhibitors besides BP levels and the general
use of antihypertensive drugs. ACE inhibitors (and angio-
tensin receptor blockers [ARB], especially combinations of
diuretics and ACE inhibitors/ARB) are contraindicated in
children with suspected RVH, single kidneys, already
impaired renal function, and especially in children with
bilateral RAS.7 Medication included ACE inhibitors post-
operatively and at the time of follow-up (n ¼ 3; 1 each in
combination with diuretics), without any signs of renal
affection or complications occurring as in Stanley’s study.29
As ACE inhibitors did not negatively inﬂuence renal function
it was decided not to consider them as a marker for
severity. However, monitoring of renal function with renal
scintigraphy is strongly recommended and important to
avoid GFR reduction and severe acute renal failure with
sometimes irreversible kidney damage.7
CONCLUSION
Surgical treatment for pediatric RVH is possible and suc-
cessful in nearly every type of disease and age. Of course
exceptions exist, and some patients will need reoperations
because they are growing and not every reconstruction and
replacement material will sufﬁciently grow with the patient;
but on a long-term basis hypertension can be cured or at
least greatly improved. However, patients will need lifelong
follow-up examination and BP measurements. Comparing
different groups, patients with isolated aortic diseases and
in the age of middle childhood may have better long-term
results than in early childhood or adolescents, but more
studies and patients are required to conﬁrm these ﬁndings.
Even in very young children, surgery can help to cure or
improve their disease e sometimes in the sense of a
bridging technique e until a deﬁnite cure can be achieved
at a more mature age. However, pediatric vascular tech-
niques are very different from reconstructive surgery in
adults and require long-time surgical experience and
expertise.
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